Fully Integrated and High‐Throughput Microfluidic System for Multiplexed Point‐Of‐Care Testing
Small · 2024-10 · 20 (43)
DOI: 10.1002/smll.202401848 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 28.06.2024. Verfasst von Shunji Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics Hubei Bioinformatics & Molecular Imaging Key Labo…. Hauptthemen laut MEDLINE: Point-of-Care Testing. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
For every epidemic outbreak, the prevention and treatments in resource‐limited areas are always out of reach. Critical to this is that high accuracy, stability, and more comprehensive analytical techniques always rely on expensive and bulky instruments and large laboratories. Here, a fully integrated and high‐throughput microfluidic system is proposed for ultra‐multiple point‐of‐care immunoassay, termed Dac system. Specifically, the Dac system only requires a handheld portable device to automatically recycle repetitive multi‐step reactions including on‐demand liquid releasing, dispensing, metering, collecting, oscillatory mixing, and discharging. The Dac system performs high‐precision enzyme‐linked immunosorbent assays for up to 17 samples or targets simultaneously on a single chip. Furthermore, reagent consumption is only 2% compared to conventional ELISA, and microbubble‐accelerated reactions shorten the assay time by more than half. As a proof of concept, the multiplexed detections are achieved by detecting at least four infection targets for two samples simultaneously on a singular chip. Furthermore, the barcode‐based multi‐target results can rapidly distinguish between five similar cases, allowing for accurate therapeutic interventions. Compared to bulky clinical instruments, the accuracy of clinical inflammation classification is 92.38% ( n = 105), with a quantitative correlation coefficient of R 2 = 0.9838, while the clinical specificity is 100% and the sensitivity is 98.93%.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics Hubei Bioinformatics & Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering, C…
- Department of Reagent Research and Development, Shenzhen YHLO Biotech Co., Ltd., Shenzhen, 518000, China.
ORCID-Profile: Bi-Feng Liu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Li, S., Zhang, Y., Liu, J., Wang, X., Qian, C., Wang, J., Wu, L., Dai, C., Yuan, H., Wan, C., Li, J., Du, W., Feng, X., Li, Y., Chen, P., & Liu, B. F. (2024). Fully Integrated and High‐Throughput Microfluidic System for Multiplexed Point‐Of‐Care Testing. Small, 20(43). https://doi.org/10.1002/smll.202401848
Vancouver
Li S, Zhang Y, Liu J, Wang X, Qian C, Wang J, et al. Fully Integrated and High‐Throughput Microfluidic System for Multiplexed Point‐Of‐Care Testing. Small. 2024;20(43). doi:10.1002/smll.202401848
BibTeX
@article{Li2024,
author = {Li, Shunji and Zhang, Ying and Liu, Jingxuan and Wang, Xing and Qian, Chungen and Wang, Jingjing and Wu, Liqiang and Dai, Chenxi and Yuan, Huijuan and Wan, Chao and Li, Jiashuo and Du, Wei and Feng, Xiaojun and Li, Yiwei and Chen, Peng and Liu, Bi-Feng},
title = {Fully Integrated and High‐Throughput Microfluidic System for Multiplexed Point‐Of‐Care Testing},
journal = {Small},
year = {2024},
volume = {20},
number = {43},
doi = {10.1002/smll.202401848}
}
EUVIMED